Nautilus Biotechnolgy, Inc.
NASDAQ: NAUT0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Nasdaq Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Sujal Patel
- Employees
- 130
- Headquarters
- Seattle, United States
- IPO year
- 2020
- Market cap
- $299.9M
- Website
- https://www.nautilus.bio
Loading NAUT…
Loading profile data…Frequently asked questions about NAUT
What does Nautilus Biotechnolgy, Inc. (NAUT) do?
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising instruments, reagents, consumables, and software ana...
Where does NAUT trade?
Nautilus Biotechnolgy, Inc. (NAUT) trades on the Nasdaq Capital Market.
What sector is NAUT in?
Nautilus Biotechnolgy, Inc. (NAUT) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Nautilus Biotechnolgy, Inc.?
Sujal Patel is the chief executive officer of Nautilus Biotechnolgy, Inc. (NAUT).
Where is Nautilus Biotechnolgy, Inc. headquartered?
Nautilus Biotechnolgy, Inc. is headquartered in United States.
Does NAUT pay a dividend?
Nautilus Biotechnolgy, Inc. (NAUT) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NAUT go public?
Nautilus Biotechnolgy, Inc. (NAUT) completed its initial public offering in 2020.